Back to results
US 12,146,167 B2Granted
Enzymatic method for producing L-glufosinate and its phosphoesters
AssigneeEvonik Operations GmbH
InventorsMarkus Pötter, Ludger Lautenschütz, Daniel Fischer, Jakob Müller
Life of this patent
Estimating the term…
Abstract
An enzymatically catalyzed method for producing L-glufosinate or a phosphoester of L-glufosinate can be performed. An activated L-homoserine HA is reacted with a substrate S selected from methylphosphinic acid and the esters of methylphosphinic acid. The method makes accessible new substrates in the enzymatic production of L-glufosinate and its phosphoesters.
Claims11
An enzymatically catalyzed method for producing L-glufosinate or a phosphoester thereof, the method comprising:
- reacting an activated L-homoserine HA with a substrate S of the following structure (I) to produce a compound of the following structure (III),
- wherein R1 is selected from the group consisting of hydrogen, an alkyl, an alkenyl, an alkinyl, a hydroxyalkyl, and an aryl, and
- wherein the activated L-homoserine HA has the following structure (II):
- wherein R2 is a hydrocarbon group with 1 to 15 carbon atoms which optionally comprises at least one functional group selected from OH, COOH, NH, and
- wherein the reaction is catalyzed by at least one enzyme selected from the group consisting of a sulfhydrylase and a cystathionine γ-synthase,
- wherein the sulfhydrylase comprises a polypeptide sequence selected from the group consisting of SEQ ID NO:
- 2 and variants of SEQ ID NO:
- 2, SEQ ID NO:
- 6 and variants of SEQ ID NO:
- 6, SEQ ID NO:
- 19 and variants of SEQ ID NO:
- 19, SEQ ID NO:
- 22 and variants of SEQ ID NO:
- 22, SEQ ID NO:
- 23 and variants of SEQ ID NO:
- 23, SEQ ID NO:
- 10 and variants of SEQ ID NO:
- 10, SEQ ID NO:
- 14 and variants of SEQ ID NO:
- 14, SEQ ID NO:
- 18 and variants of SEQ ID NO:
- 18, SEQ ID NO:
- 20 and variants of SEQ ID NO:
- 20, SEQ ID NO:
- 24 and variants of SEQ ID NO:
- 24, SEQ ID NO:
- 25 and variants of SEQ ID NO:
- 25, SEQ ID NO:
- 26 and variants of SEQ ID NO:
- 26, SEQ ID NO:
- 27 and variants of SEQ ID NO:
- 27, SEQ ID NO:
- 28 and variants of SEQ ID NO:
- 28, and SEQ ID NO:
- 34 and variants of SEQ ID NO:
- 34,
- wherein the variants of SEQ ID NOs:
- 2, 6, 10, 14, 18-20, 22-28, and 34 are defined as polypeptide sequences with at least 95% sequence identity to SEQ ID NOs:
- 2, 6, 10, 14, 18-20, 22-28, and 34 respectively, and
- wherein the cystathionine y-synthase comprises a polypeptide sequence selected from the group consisting of SEQ ID NO:
- 17 and variants of SEQ ID NO:
- 17. SEQ ID NO:
- 21 and variants of SEQ ID NO:
- 21, SEQ ID NO:
- 29 and variants of SEQ ID NO:
- 29, SEQ ID NO:
- 30 and variants of SEQ ID NO:
- 30, SEQ ID NO:
- 31 and variants of SEQ ID NO:
- 31, SEQ ID NO:
- 32 and variants of SEQ ID NO:
- 32, and SEQ ID NO:
- 33 and variants of SEQ ID NO:
- 33,
- wherein the variants of SEQ ID NOs:
- 17, 21, and 29-33 are defined as polypeptide sequences with at least 95% sequence identity to SEQ ID NOs:
- 17, 21, and 29-33 respectively.
54 more elements
Dependencies are inferred from the claim text.